Community-acquired pneumonia: economics of inpatient medical care vis-à-vis clinical severity

Jornal brasileiro de pneumologia : publicaça̋o oficial da Sociedade Brasileira de Pneumologia e Tisilogia
Vojislav CupurdijaMihajlo Jakovljevic

Abstract

To assess the direct and indirect costs of diagnosing and treating community-acquired pneumonia (CAP), correlating those costs with CAP severity at diagnosis and identifying the major cost drivers. This was a prospective cost analysis study using bottom-up costing. Clinical severity and mortality risk were assessed with the pneumonia severity index (PSI) and the mental Confusion-Urea-Respiratory rate-Blood pressure-age ≥ 65 years (CURB-65) scale, respectively. The sample comprised 95 inpatients hospitalized for newly diagnosed CAP. The analysis was run from a societal perspective with a time horizon of one year. Expressed as mean ± standard deviation, in Euros, the direct and indirect medical costs per CAP patient were 696 ± 531 and 410 ± 283, respectively, the total per-patient cost therefore being 1,106 ± 657. The combined budget impact of our patient cohort, in Euros, was 105,087 (66,109 and 38,979 in direct and indirect costs, respectively). The major cost drivers, in descending order, were the opportunity cost (lost productivity); diagnosis and treatment of comorbidities; and administration of medications, oxygen, and blood derivatives. The CURB-65 and PSI scores both correlated with the indirect costs of CAP treatment. Th...Continue Reading

References

Sep 18, 1999·Respirology : Official Journal of the Asian Pacific Society of Respirology·L K Hoe, L T Keang
Feb 6, 2007·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Lionel A MandellUNKNOWN American Thoracic Society
Apr 3, 2008·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Mihajlo JakovljevicSlobodan M Jankovic
Jul 19, 2008·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Qing-tao ZhouHong Zhu
Feb 19, 2011·Alcohol and Alcoholism : International Journal of the Medical Council on Alcoholism·Mirjana Jovanovic, Mihajlo Jakovljevic
Nov 2, 2011·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·M WoodheadUNKNOWN Joint Taskforce of the European Respiratory Society and European Society for Clinical Microbiology and Infectious Diseases
Sep 8, 2012·The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care·Peter Zweifel
Nov 13, 2012·The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care·Mihajlo B Jakovljevic

❮ Previous
Next ❯

Citations

May 4, 2017·Health Services Research and Managerial Epidemiology·Natasa MihailovicMihajlo Jakovljevic
Oct 24, 2019·Jornal brasileiro de pneumologia : publicaça̋o oficial da Sociedade Brasileira de Pneumologia e Tisilogia·Lessandra MichelinMaria Carolina Gullo
Feb 19, 2020·The American Journal of Tropical Medicine and Hygiene·Lora L SabinDavidson H Hamer
Nov 20, 2019·PloS One·Joel Amenya MachukiMaricianah Atieno Onono
May 31, 2019·Transplant International : Official Journal of the European Society for Organ Transplantation·Bassem HamandiEmmanuel A Papadimitropoulos
Jan 11, 2020·Frontiers in Public Health·Kristijan KrsticMihajlo B Jakovljevic

❮ Previous
Next ❯

Methods Mentioned

BETA
X-ray

Software Mentioned

SPSS

Related Concepts

Related Feeds

Bacterial Pneumonia (ASM)

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Bacterial Pneumonia

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.